| Literature DB >> 25921292 |
Cédric Chaveroux1, Valérie Carraro1, Laurence Canaple2, Julien Averous1, Anne-Catherine Maurin1, Céline Jousse1, Yuki Muranishi1, Laurent Parry1, Florent Mesclon1, Evelina Gatti3, Jacques Mallet4, Philippe Ravassard4, Philippe Pierre3, Pierre Fafournoux5, Alain Bruhat5.
Abstract
The eIF2α-ATF4 pathway is involved in cellular adaptation to stress and is dysregulated in numerous diseases. Activation of this pathway leads to phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2α) and the recruitment of the transcription factor ATF4 (activating transcription factor 4) to specific CCAAT/enhancer binding protein (C/EBP)-ATF response elements (CAREs) located in the promoters of target genes. To monitor the spatiotemporal modulation of this pathway in living animals, we generated a novel CARE-driven luciferase mouse model (CARE-LUC). These transgenic mice enable the investigation of the eIF2α-ATF4 pathway activity in the whole organism and at the tissue and cellular levels by combining imaging, luciferase assays, and immunochemistry. Using this mouse line, we showed the tissue-specific activation pattern of this pathway in response to amino acid deficiency or endoplasmic reticulum stress and the hepatic induction of this pathway in a stress-related pathology model of liver fibrosis. The CARE-LUC mouse model represents an innovative tool to investigate the eIF2α-ATF4 axis and to develop drugs targeting this important pathway in the remediation of related pathologies.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25921292 DOI: 10.1126/scisignal.aaa0549
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192